Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page footer’s revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded new disease terms (primary peritoneal carcinoma and fallopian tube cancer) and new resources (Genetic and Rare Diseases Information Center; MedlinePlus Genetics). Updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-visible changes to study details or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.